Perspectives from Christian Angermayer, investor and founder in psychedelics
Business Trip, a podcast about psychedelic startups
Welcome back to Business Trip, a podcast about psychedelic startups! 🍄
In this week’s episode, we chat with Christian Angermayer. Christian co-founded atai Life Sciences and was an early investor in Compass Pathways -- two of the first companies commercializing psychedelic medicine. Christian also launched a fund dedicated to mental and neurological health called re:Mind, is an investor through his family office Apeiron, and co-founded two longevity biotech companies.
In this episode, we discuss:
What the psychedelic field will look like in the next couple years
His views on patents, ketamine telehealth, & 1st vs. 2nd gen psychedelics
Fundraising tips for founders
How he generates investment ideas
Learnings from his own psychedelic experiences
When you’re done listening, tweet at us @businesstripfm to share your thoughts!
Business Trip is a podcast about psychedelic startups. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.
Thanks for listening,
💖 Know someone who would enjoy Business Trip?